Trial intelligence / Profile preview

Myfortic vs Cellcept in Kidney Transplant Recipients

NCT00533624Phase 3Completed

Sponsor
University of Miami
Start
Dec 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mycophenolate sodium in kidney transplant rejection, sponsored by University of Miami. Started Dec 2004; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00533624.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00533624.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call